HIGHLIGHTS
- who: Rosaria Vincenza Giglio et al. from the Department of Biomedicine, Neuroscience, and Advanced Diagnostics, University of Palermo, Palermo, Italy have published the Article: An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes, in the Journal: Medicina 2022, 1475 of /2022/
SUMMARY
Important intervention studies to prevent or reduce the impact of micro/macrovascular consequences in Type 2 Diabetes_Mellitus (T2DM) have established the importance of adequate glycemic control. This important molecular effect has been proposed as a key mechanism by which GLP-1 agonists are able to have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.